Glenhill Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-711,382
Closed -$11.7M 49
2017
Q3
$11.7M Sell
711,382
-68,735
-9% -$1.17M 0.95% 30
2017
Q2
$15.1M Sell
780,117
-39,487
-5% -$689K 0.95% 29
2017
Q1
$14.5M Buy
+819,604
New +$15.2M 1.12% 31
2016
Q3
Sell
-1,297,696
Closed -$35.9M 47
2016
Q2
$35.9M Sell
1,297,696
-695,554
-35% -$20.6M 2.59% 14
2016
Q1
$57.7M Sell
1,993,250
-199,497
-9% -$5.19M 3.5% 10
2015
Q4
$66.4M Buy
+2,192,747
New +$71.9M 4.93% 7

Other funds holding THC

Glenhill Advisors's THC Position: Q4 2017 in Review

Glenhill Advisors sold out of Tenet Healthcare (THC) in Q4 2017, closing a stake of 711,382 shares — an estimated $11.7M sold.

Glenhill Advisors first reported a position in THC in Q4 2015 and held it in 6 quarters. The position peaked at $66.4M in Q4 2015. 233 funds tracked by Wall St. Rank hold THC as of Q4 2017.

  • Glenhill Advisors reported no remaining Tenet Healthcare position as of Q4 2017 after selling out during the quarter.
  • Glenhill Advisors sold 711,382 Tenet Healthcare shares in Q4 2017, an estimated $11.7M.
  • Glenhill Advisors first reported a position in Tenet Healthcare in Q4 2015 and held it in 6 quarters.
  • Glenhill Advisors's Tenet Healthcare position peaked at $66.4M in Q4 2015.
  • 233 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2017.

Based on Glenhill Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.